About this event
On March 16th at 11:00 AM PDT, our Chief Strategy Officer Ted Bird and Chief Operating Officer, Jeff Bennett, will host a live investor Q&A.
Ted and Jeff will talk about the current problems with current spinal treatments and the innovation behind the Triadyme-C.
In addition to these topics, you will have a chance to get your questions answered live!
Space is limited, so book your seat now!
Hosted by